Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution
Filter News
Show All Results
News By Country
News By Tag
Gpcr Remove


December 2014
Su Sa Fr Th We Tu Mo
21 20 19 18 17 16 15

gpcr Press Releases

  + XML/RSS  



By Cambridge Healthtech Institute
Top scientists from pharma and biotech to deliver new data and case studies for using structure and rational design to accelerate discovery

By SMi Group
SMi are delighted to announce that Roche will now be speaking at the 13th annual conference on Advances and Progress in Drug Design taking place next February in London.

By Cambridge Healthtech Institute
Presentation download from the Structure-Based Drug Design 2012 conference organized by Cambridge Healthtech Institute & Bio-IT World

By Cambridge Healthtech Institute
Event Focus will be Predicting Biological and Kinetic Profiles from Structure

By Cambridge Healthtech Institute
CHI and Bio-IT World's "Structure-Based Design" Conference to be held on June 8-10, 2011 in Cambridge, MA, will feature a new session: New Targets and Drug Modalities

By Visiongain Ltd.
GPCR & Kinase Targets Advances in drug discovery from molecular to clinical 14th - 15th April 2011, Thistle City Barbican, London, UK

By visiongain
Comprising more than 60% of all therapeutic targets, G-protein coupled receptor and kinase targets are arguably the most exciting proteins in pharmacology today. Find out more by attending this key event

By Cambridge Healthech Institute
Cambridge Healthtech Institute, a premier information provider for the life sciences industry, will host its Eighth International Discovery on Target meeting on November 2-4, 2010 in Boston, Massachusetts.

By Fast Market Research
New Pharmaceuticals market report from Business Insights: "The Future of GPCRs in Drug Discovery: Novel technologies, leading companies, and opportunities for target expansion"

By Ekta Ahuja
Executives from Heptares Therapeutics (Welwyn Garden City, UK) and O2h (Cambridge, UK) announced today an extension of the agreement under which O2h provides multi-FTE -synthetic chemistry services to support discovery programmes at Heptares.

By Andrey Grischenko
Otava releases two GPCR-related focused libraries. The libraries have been designed with QSAR using training set. These libraries are proposed for screening in GPCR-associated research and drug development.

By Sally Wang
GenScript's Ready-to-UseTM frozen cell series is designed to expedite cellular assays.



Page updated every 10 minutes


  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
9K2K1K
Click to Share